That’s true. At one point all the rusted on true believers were saying Novartis was going to be the big multinational with the gravitas to validate it all with a big deal with MSB… then Novartis having taken a closer look, walked alway and the die hard fans did a 180 and then suddenly claimed Novartis have no idea and know nothing because what happened did not suit their narrative.
Apparently, Novartis’ deep expertise and due diligence is not better than a rusted on arm chair investor facing capital losses of 90% over 20 years.
Growing doubt on COVID-19 Application, page-3751
-
- There are more pages in this discussion • 984 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.31 |
Change
-0.010(0.76%) |
Mkt cap ! $1.495B | |||
| Open | High | Low | Value | Volume |
| $1.31 | $1.33 | $1.28 | $1.819M | 1.396M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 29972 | $1.31 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.31 | 2008 | 1 |
View Market Depth
| Last trade - 16.10pm 01/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |